KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 257 filers reported holding KARUNA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $12,702,422 | +30.8% | 58,577 | +9.6% | 0.50% | +34.3% |
Q1 2023 | $9,709,021 | -7.6% | 53,452 | 0.0% | 0.37% | -6.8% |
Q4 2022 | $10,503,318 | +97.7% | 53,452 | +126.3% | 0.40% | +82.9% |
Q3 2022 | $5,312,000 | -46.9% | 23,616 | -70.1% | 0.22% | -44.8% |
Q2 2022 | $10,002,000 | -21.5% | 79,057 | -21.3% | 0.39% | -12.1% |
Q1 2022 | $12,737,000 | -3.2% | 100,458 | 0.0% | 0.45% | +5.7% |
Q4 2021 | $13,160,000 | +7.1% | 100,458 | 0.0% | 0.42% | +6.8% |
Q3 2021 | $12,289,000 | +7.3% | 100,458 | 0.0% | 0.40% | +6.5% |
Q2 2021 | $11,451,000 | +11.7% | 100,458 | +17.9% | 0.37% | +5.4% |
Q1 2021 | $10,248,000 | +18.4% | 85,236 | 0.0% | 0.35% | +16.1% |
Q4 2020 | $8,659,000 | +167.7% | 85,236 | +103.8% | 0.30% | +151.2% |
Q3 2020 | $3,234,000 | -2.9% | 41,827 | +40.0% | 0.12% | -4.7% |
Q2 2020 | $3,330,000 | – | 29,873 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |